Gnosis is preparing to launch what it claims is the first non-animal-derived chondroitin sulphate (CS) product, Mythocondro. It says this eliminates problems with adulteration and consistency.
new trial shows supplement reduced pain to same level as drug treatment
Combined supplementation with chondroitin sulphate and glucosamine could help to reduce knee joint pain, stiffness, and functional disability of people with osteoarthritis, say researchers.
Long term administration of high purity and concentrated chondroitin sulphate may prevent degradation in the joint structure of people suffering from osteoarthritis, says a new study.
New Zealand's Waitaki Biosciences is affirming its position in the
joint health market with the European launch of a new ingredient
named Calcium Peptacan at HIE in Frankfurt this week.
Two long-awaited clinical trials on glucosamine have found the
shellfish-derived substance to significantly reduce the pain of
arthritic joints, and it may be better than a commonly used
painkiller in Europe.
UK fish oils supplier Croda Health Care is launching a new joint
care complex based on type II collagen and chondroitin sulphate,
expanding its offering for this booming nutraceuticals category.
Leading orthopaedic surgeons and pharmacologists have confirmed
their backing for chondroitin sulphate supplements as a way of
managing joint discomfort, according to one supplement
manufacturer.